Cardiometabolic Disorders

Top Story

Obesity drives risk for heart disease, requires collaboration

Obesity drives risk for heart disease, requires collaboration
November 13, 2018
Meeting NewsPerspective

Antisense oligonucleotide reduces Lp(a) in patients at high residual risk

November 11, 2018
CHICAGO — An N-acetyl-galactosamine-conjugated antisense oligonucleotide significantly reduced lipoprotein(a), oxidized phospholipid apolipoprotein B, oxidized…
Meeting NewsPerspective

VITAL: Vitamin D, omega-3 fail to reduce major CV events, cancer

November 10, 2018
CHICAGO — In the large-scale VITAL trial, neither omega-3 nor vitamin D supplements for primary prevention reduced major CV events or development of invasive…
Meeting NewsPerspective

DECLARE-TIMI 58: Dapagliflozin reduces HF hospitalization in type 2 diabetes

November 10, 2018
CHICAGO — The DECLARE-TIMI 58 trial of dapagliflozin in patients with type 2 diabetes who had or were at high risk for atherosclerotic CVD adds to the growing body…
More Headlines »
ABIM MOC CME

Ace the Case: 65-Year-Old Man with Type 2 Diabetes and Newly Diagnosed Cardiovascular Disease

No commercial support for this activity.

This CME activity will use a case study to discuss the management of a 65-year-old man with T2DM, obesity, and a recent…
More »
Video
Meeting News

In type 2 diabetes, consider disease burden when managing blood pressure

May 18, 2018
More »
CME ABIM MOC

Goal-directed Therapy in Osteoporosis: Reaching a Consensus

This activity is supported by an educational grant from Radius Health, Inc.

Osteoporosis, a disorder characterized by compromised bone strength that increases the risk of fragility, leads to 1.5…
More »